Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis Transcript

SignalsMonitor is following this as a markets story. Seeking Alpha is the outlet attached so far. The first report grouped here was at 30 Sept 2026, 20:22 UTC. 2 material updates are listed in the timeline. The headline in use is “Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis Transcript”. This note is SignalsMonitor's own briefing, not the publisher's article.